Evocutis plc (AIM:EVO), the company focused on advanced laboratory and clinical evaluations of skincare products for the health and cosmetic markets, is pleased to announce the opening of a dedicated Skin Histology Laboratory at their Wetherby site.

The Evocutis Skin Histology Laboratory provides services dedicated to cutaneous biology, including sample processing, imaging, reporting and consultancy. The new laboratory complements Evocutis' existing portfolio of skincare development services in laboratory and clinical testing and is particularly tightly integrated with the LabSkin™ in vitro skin model production and testing facility. The combination of specialist Skin Histology facilities and testing using LabSkin™ enables customers to conduct animal-free assessments of their ingredients and products for multiple parameters including irritation, penetration, UV damage and antimicrobial activity.

Dr. Richard Bojar, Chief Scientific Officer of Evocutis, says: "Our Skin Histology Laboratory is equipped with the most advanced sample processing kit, providing our skilled and dedicated staff with state-of-the art facilities. We are now producing highly consistent skin sections from our LabSkin™ model, which produce stunning images of colonising microorganisms. The dedicated Skin Histology Laboratory allows interactive, real-time experimentation which provides customers with innovative and valuable data to support their product development. Evocutis' on-going R&D programme to develop and expand the range of LabSkin™ models as a platform for testing skincare products will enable the Skin Histology Laboratory to provide further services in the future".

Click here to download full press release.